Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Alvotech Holdings S.A.

Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
Alvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock Exchange
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
FDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®
From Alvotech Holdings S.A.
Via Business Wire
Alvotech and Fuji Pharma Expand Partnership for Additional Biosimilar Candidate in Japan
From Alvotech Holdings S.A.
Via Business Wire
Alvotech Enters Exclusive Global Licensing Agreement with BiosanaPharma for Co-Development of a Proposed Biosimilar (AVT23) to Xolair® (Omalizumab)
From Alvotech Holdings S.A.
Via Business Wire
Alvotech Upsizes Oversubscribed PIPE Transaction to Approximately $175 Million
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company
From Alvotech Holdings S.A.
Via Business Wire
Tickers OACB
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.